4th World ADC Asia Summit
R&D
Kickstart Your 2025 ADC Development at the 4th World ADC Asia Summit
The 4th World ADC Asia Summit is back, offering the most comprehensive platform for Asia’s rapidly growing ADC community. This summit brings together cutting-edge innovators from Asia alongside expertise from the West to chart a path to ADC success across the region.
With a stellar lineup of 40+ industry-leading speakers from Asia, the EU, and the US, here’s a snapshot of who you could meet this June:
- Dongzhou Liu, Chief Scientific Officer, Huadong Medicine
- Doo Young Jung, Chief Executive Officer, Pinotbio
- Gilles Gallant, Chief Development Officer, Mythic Therapeutics
- Haiqing Hua, Head of Drug Discovery & Senior Vice President, Duality Biologics
- Markus Schick, Director & Head of Computational Pathology & Biomarker Development, AstraZeneca
- Martha Li, CDx Strategy Lead, Abbvie
Key Themes & Sessions Include:
- Discovery: Uncover Asia’s cutting-edge innovations in linker payloads, chemistry, and ADC targets. Hear from Huadong Medicine, OBI Pharma, Chiome Bioscience, and more.
- Preclinical & Clinical: Refine your concept-to-clinic strategy with expert insights on clinical validation, patient selection, and biomarker strategies from Daiichi Sankyo, AimedBio, PinotBio, and Heidelberg Pharma.
- CMC: Gain essential strategies on analytical and process development, scaling up, and collaborating with CDMOs to meet tight timelines, featuring experts from Exelixis, Duality Biologics, and GeneQuantum.
- Novel Modalities: Dive into next-gen ADC formats like bispecific ADCs and degrader-antibody conjugates, with presentations from OBI Pharma, PinotBio, Duality Biologics, and Orum Therapeutics.
For full event details, speaker faculty, and session breakdowns, download the event guide today.
This is your chance to forge valuable partnerships that can drive the success of your ADC initiatives to new heights.
